Advertisement
Advertisement
LUCD
Lucid Diagnostics Inc. Common Stock
1.22
USDSponsored
+0.07
+5.65%
Feb 06, 15:55 UTC -5
Closed
After-Market
1.21
-0.01
-0.41%
LUCD Earnings Reports
Positive Surprise Ratio
LUCD beat 7 of 17 last estimates.
41%
Next Report
Date of Next Report
Mar 23, 2026
Estimate for Q4 25 (Revenue/ EPS)
$1.42M
/-$0.10
Implied change from Q3 25 (Revenue/ EPS)
+16.89%
/--
Implied change from Q4 24 (Revenue/ EPS)
+18.26%
/-44.44%
Lucid Diagnostics Inc. Common Stock earnings per share and revenue
On Nov 12, 2025, LUCD reported earnings of -0.10 USD per share (EPS) for Q3 25, beating the estimate of -0.11 USD, resulting in a 11.03% surprise. Revenue reached 1.21 million, compared to an expected 1.38 million, with a -12.52% difference. The market reacted with a +6.73% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 analysts forecast an EPS of -0.10 USD, with revenue projected to reach 1.42 million USD, implying an increase of 0.00% EPS, and increase of 16.89% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Mesa Laboratories Inc
Report Date
Feb 03, 2026 For Q3 26
Estimate
$0.28
Actual
$3.07
Surprise
+987.88%
Accuray Incorporated
Report Date
Feb 04, 2026 For Q2 26
Estimate
-$0.11
Actual
-$0.11
Surprise
+1.96%
Thermo Fisher Scientific, Inc.
Report Date
Jan 29, 2026 For Q4 25
Estimate
$6.51
Actual
$6.57
Surprise
+0.91%
Idexx Laboratories Inc
Report Date
Feb 02, 2026 For Q4 25
Estimate
$2.98
Actual
$3.08
Surprise
+3.12%
IQVIA Holdings Inc.
Report Date
Feb 05, 2026 For Q4 25
Estimate
$3.43
Actual
$3.42
Surprise
-0.34%
Mettler-Toledo International
Report Date
Feb 05, 2026 For Q4 25
Estimate
$12.92
Actual
$13.36
Surprise
+3.34%
STERIS plc
Report Date
Feb 04, 2026 For Q3 26
Estimate
$2.55
Actual
$2.52
Surprise
-0.99%
Hologic Inc
Report Date
Jan 29, 2026 For Q1 26
Estimate
$1.11
Actual
$1.04
Surprise
-6.45%
FAQ
What were Lucid Diagnostics Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Lucid Diagnostics Inc. Common Stock reported EPS of -$0.10, beating estimates by 11.03%, and revenue of $1.21M, -12.52% below expectations.
How did the market react to Lucid Diagnostics Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 6.73%, changed from $1.04 before the earnings release to $1.11 the day after.
When is Lucid Diagnostics Inc. Common Stock expected to report next?
The next earning report is scheduled for Mar 23, 2026.
What are the forecasts for Lucid Diagnostics Inc. Common Stock's next earnings report?
Based on 8
analysts, Lucid Diagnostics Inc. Common Stock is expected to report EPS of -$0.10 and revenue of $1.42M for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement